Judgment rendered April 8, 2026. Application for rehearing may be filed within the delay allowed by Art. 2166, La. C.C.P.
No. 56,803-CA
COURT OF APPEAL SECOND CIRCUIT STATE OF LOUISIANA
*****
CHRISTOPHER SPIRES AND Plaintiffs-Appellants LAURA LIVELY, INDIVIDUALLY AND ON BEHALF OF NOLAN SPIRES, A MINOR versus
ST. FRANCIS MEDICAL CENTER, Defendants-Appellees MARC DE SOLER, M.D. AMANDA CARNES, NNP, AND KATHLEEN LIRETTE, NNP *****
Appealed from the Fourth Judicial District Court for the Parish of Ouachita, Louisiana Trial Court No. 2022-0562
Honorable Frederick D. Jones, Judge
KARL BERNARD LAW, LLC Counsel for Appellants By: G. Karl Bernard
NELSON, ZENTNER, SARTOR, & Counsel for Appellees, SNELLINGS, LLC Amanda Carnes, NNP, By: David H. Nelson and Kathleen Lirette, NNP
HUDSON, POTTS & BERNSTEIN, LLP Counsel for Appellee, By: Gordon L. James Marc de Soler, M.D. Donald H. Zeigler, III
BREAZEALE, SACHSE & WILSON, LLP Counsel for Appellee, By: Thomas Richard Temple, Jr. St. Francis Medical Center Alexa Nicole Candelora
Before PITMAN, STEPHENS, and ROBINSON, JJ. PITMAN, C. J.
Plaintiffs Christopher Spires and Laura Lively, individually and on
behalf of their minor child, Nolan Spires, appeal the summary judgments
granted in this medical malpractice suit in favor of Defendants Marc
De Soler, M.D., Amanda Carnes, NNP, and Kathleen Lirette, NNP. For the
following reasons, we affirm the granting of the summary judgments.
FACTS
Plaintiffs filed suit for medical malpractice against St. Francis
Medical Center (“St. Francis”), Dr. Marc De Soler and nurse practitioners
Amanda Carnes and Kathleen Lirette.
Nolan was born at University Health-Monroe via Cesarean-section at
37 weeks’ gestation on October 11, 2017. His APGAR scores (a rapid, 10-
point assessment of a newborn’s health, calculated at one and five minutes
after birth) were good, 9 and 9 (normal is 7-10), but he subsequently began
developing signs of respiratory distress. He was originally placed on a
Continuous Positive Airway Pressure (CPAP) machine and had acceptable
oxygen saturations, but his distress worsened. He was transferred to the
neonatal intensive care unit at St. Francis.
At St. Francis, Nolan was intubated, and it was discovered that he had
developed a right-sided pneumothorax requiring placement of a chest tube.
His respiratory acidosis eventually resolved, and his blood gases improved.
His distress was diagnosed as a condition called transient tachypnea of the
newborn. On October 12, 2017, Nolan began having seizure-like symptoms,
which lasted for 30 to 45 minutes and continued intermittently. Nurse
practitioner Carnes notified Dr. De Soler, the neonatal medical specialist and
lead physician on his case. Nolan was given Ativan; Cerebyx (Dilantin) and phenobarbital to control the seizure symptoms. He was administered these
drugs at certain intervals with Dr. De Soler testing his toxicity levels several
times. The doctor noted in the discharge summary:
The infant had a phenobarbital level of 33 on 10/14 at 5:30 and had a Dilantin level of 55 on 10/14 at 5:30 a.m., after the infant received a bolus of Cerebyx at 0555 hours, just before obtaining the level. I repeated the Dilantin level at 1300 hours on 10/14, about 8 hours after the bolus was given and it was 69.
Plaintiffs alleged that Dr. De Soler administered the bolus of Cerebyx
prior to receiving the results of the level that had been taken at 5:30 a.m. and
that this mistake caused their son’s resulting damages.1 They claim that
almost immediately after the Cerebyx was administered at 5:55 a.m., Nolan
experienced a sudden hemodynamic deterioration, which resulted in heart
rate readings in the 60s. A Code Blue was called, he was intubated and
required chest compressions, and a needle was inserted into his left chest
without return of air. He was very hypotensive and an EKG was performed,
which revealed a stiff heart with poor relaxation and contraction of the heart.
Bilateral pneumothorax was identified by chest X-ray and tubes were placed.
Plaintiffs claimed that after more than two days of steady decline and failure
of the physician and staff to stabilize him, plans were made to transfer Nolan
to Children’s Hospital of New Orleans, a facility which could provide a
higher level of care. However, when the crew arrived to transfer him, Nolan
was too unstable to be immediately transported.
1 The results of the test were not available until 7:14 a.m. The medical review panel addressed this issue in its report, noted the time of the testing and the administration of the bolus of Cerebyx, and stated, “To expect the lab work report on Dilantin to be returned quickly is unreasonable. The Dilantin level of 55.8 was reported at 7:14 am. The evidence indicates Dr. De Soler was notified promptly and discontinued the Cerebyx. Prior to this, the infant had a cardiac respiratory arrest, which was managed appropriately. Subsequent Dilantin level showed an increase to 69.8. The evidence supports Dr. De Soler’s efforts to determine the etiology of the high rise of levels, including metabolism disorder.” 2 When he ultimately arrived in New Orleans on October 15, 2017, it
was discovered that Nolan was suffering from Dilantin toxicity, and
appropriate treatment began. Nolan remained in New Orleans until
December 2, 2017. During his stay, he required several interventions,
including an extracorporeal membrane oxygenation (ECMO) procedure to
serve as a bypass for a poorly functioning circulatory and respiratory system.
Plaintiffs assert that Nolan now suffers with developmental, cognitive,
motor, speech and social/behavioral delays. He cannot understand
nonverbal communications, walk or use the restroom independently and has
bouts of emotional distress and other deficits.
Following the filing of Plaintiffs’ original medical malpractice claim
against Defendants, the medical review panel (“MRP”) published its opinion
entitled, “Opinion and Written Reasons for Conclusion.” A case report
attached to the MRP’s written reasons is in the original record of this suit
and is entitled, “Cardia Collapse Secondary to Phenytoin Toxicity in a
Neonate Treated with Extracorporeal Membrane Oxygenation Support.”
Plaintiffs alleged that this report is based on Nolan’s medical history and
was published in the Journal of Medical Toxicology in November 2019.2 It
found that although medication overdose and toxicity are uncommon in
neonates, some medications pose a risk. One of those is Fosphenytoin,
which is sold under the name Cerebyx.
The MRP found that the evidence presented supported the conclusion
that St. Francis and its staff, particularly the pharmacy staff, failed to meet
2 Defendants alleged that the case study, while attached to the MRP’s written opinion and seeming to be exactly descriptive of Nolan’s case, never mentions him by name. This was not an issue until the case was later appealed to this court after rendition of the reconsideration of the summary judgment at issue in this appeal. 3 the applicable standard of care as charged in the complaint and that the
conduct complained of was a factor in the resulting damages. Specifically,
the MRP stated that the pharmacy staff of St. Francis failed particularly in
the preparation of the dose and delivery of the Cerebyx, which was
“inappropriate and incorrect, leading to the Dilantin toxicity and level
Free access — add to your briefcase to read the full text and ask questions with AI
Judgment rendered April 8, 2026. Application for rehearing may be filed within the delay allowed by Art. 2166, La. C.C.P.
No. 56,803-CA
COURT OF APPEAL SECOND CIRCUIT STATE OF LOUISIANA
*****
CHRISTOPHER SPIRES AND Plaintiffs-Appellants LAURA LIVELY, INDIVIDUALLY AND ON BEHALF OF NOLAN SPIRES, A MINOR versus
ST. FRANCIS MEDICAL CENTER, Defendants-Appellees MARC DE SOLER, M.D. AMANDA CARNES, NNP, AND KATHLEEN LIRETTE, NNP *****
Appealed from the Fourth Judicial District Court for the Parish of Ouachita, Louisiana Trial Court No. 2022-0562
Honorable Frederick D. Jones, Judge
KARL BERNARD LAW, LLC Counsel for Appellants By: G. Karl Bernard
NELSON, ZENTNER, SARTOR, & Counsel for Appellees, SNELLINGS, LLC Amanda Carnes, NNP, By: David H. Nelson and Kathleen Lirette, NNP
HUDSON, POTTS & BERNSTEIN, LLP Counsel for Appellee, By: Gordon L. James Marc de Soler, M.D. Donald H. Zeigler, III
BREAZEALE, SACHSE & WILSON, LLP Counsel for Appellee, By: Thomas Richard Temple, Jr. St. Francis Medical Center Alexa Nicole Candelora
Before PITMAN, STEPHENS, and ROBINSON, JJ. PITMAN, C. J.
Plaintiffs Christopher Spires and Laura Lively, individually and on
behalf of their minor child, Nolan Spires, appeal the summary judgments
granted in this medical malpractice suit in favor of Defendants Marc
De Soler, M.D., Amanda Carnes, NNP, and Kathleen Lirette, NNP. For the
following reasons, we affirm the granting of the summary judgments.
FACTS
Plaintiffs filed suit for medical malpractice against St. Francis
Medical Center (“St. Francis”), Dr. Marc De Soler and nurse practitioners
Amanda Carnes and Kathleen Lirette.
Nolan was born at University Health-Monroe via Cesarean-section at
37 weeks’ gestation on October 11, 2017. His APGAR scores (a rapid, 10-
point assessment of a newborn’s health, calculated at one and five minutes
after birth) were good, 9 and 9 (normal is 7-10), but he subsequently began
developing signs of respiratory distress. He was originally placed on a
Continuous Positive Airway Pressure (CPAP) machine and had acceptable
oxygen saturations, but his distress worsened. He was transferred to the
neonatal intensive care unit at St. Francis.
At St. Francis, Nolan was intubated, and it was discovered that he had
developed a right-sided pneumothorax requiring placement of a chest tube.
His respiratory acidosis eventually resolved, and his blood gases improved.
His distress was diagnosed as a condition called transient tachypnea of the
newborn. On October 12, 2017, Nolan began having seizure-like symptoms,
which lasted for 30 to 45 minutes and continued intermittently. Nurse
practitioner Carnes notified Dr. De Soler, the neonatal medical specialist and
lead physician on his case. Nolan was given Ativan; Cerebyx (Dilantin) and phenobarbital to control the seizure symptoms. He was administered these
drugs at certain intervals with Dr. De Soler testing his toxicity levels several
times. The doctor noted in the discharge summary:
The infant had a phenobarbital level of 33 on 10/14 at 5:30 and had a Dilantin level of 55 on 10/14 at 5:30 a.m., after the infant received a bolus of Cerebyx at 0555 hours, just before obtaining the level. I repeated the Dilantin level at 1300 hours on 10/14, about 8 hours after the bolus was given and it was 69.
Plaintiffs alleged that Dr. De Soler administered the bolus of Cerebyx
prior to receiving the results of the level that had been taken at 5:30 a.m. and
that this mistake caused their son’s resulting damages.1 They claim that
almost immediately after the Cerebyx was administered at 5:55 a.m., Nolan
experienced a sudden hemodynamic deterioration, which resulted in heart
rate readings in the 60s. A Code Blue was called, he was intubated and
required chest compressions, and a needle was inserted into his left chest
without return of air. He was very hypotensive and an EKG was performed,
which revealed a stiff heart with poor relaxation and contraction of the heart.
Bilateral pneumothorax was identified by chest X-ray and tubes were placed.
Plaintiffs claimed that after more than two days of steady decline and failure
of the physician and staff to stabilize him, plans were made to transfer Nolan
to Children’s Hospital of New Orleans, a facility which could provide a
higher level of care. However, when the crew arrived to transfer him, Nolan
was too unstable to be immediately transported.
1 The results of the test were not available until 7:14 a.m. The medical review panel addressed this issue in its report, noted the time of the testing and the administration of the bolus of Cerebyx, and stated, “To expect the lab work report on Dilantin to be returned quickly is unreasonable. The Dilantin level of 55.8 was reported at 7:14 am. The evidence indicates Dr. De Soler was notified promptly and discontinued the Cerebyx. Prior to this, the infant had a cardiac respiratory arrest, which was managed appropriately. Subsequent Dilantin level showed an increase to 69.8. The evidence supports Dr. De Soler’s efforts to determine the etiology of the high rise of levels, including metabolism disorder.” 2 When he ultimately arrived in New Orleans on October 15, 2017, it
was discovered that Nolan was suffering from Dilantin toxicity, and
appropriate treatment began. Nolan remained in New Orleans until
December 2, 2017. During his stay, he required several interventions,
including an extracorporeal membrane oxygenation (ECMO) procedure to
serve as a bypass for a poorly functioning circulatory and respiratory system.
Plaintiffs assert that Nolan now suffers with developmental, cognitive,
motor, speech and social/behavioral delays. He cannot understand
nonverbal communications, walk or use the restroom independently and has
bouts of emotional distress and other deficits.
Following the filing of Plaintiffs’ original medical malpractice claim
against Defendants, the medical review panel (“MRP”) published its opinion
entitled, “Opinion and Written Reasons for Conclusion.” A case report
attached to the MRP’s written reasons is in the original record of this suit
and is entitled, “Cardia Collapse Secondary to Phenytoin Toxicity in a
Neonate Treated with Extracorporeal Membrane Oxygenation Support.”
Plaintiffs alleged that this report is based on Nolan’s medical history and
was published in the Journal of Medical Toxicology in November 2019.2 It
found that although medication overdose and toxicity are uncommon in
neonates, some medications pose a risk. One of those is Fosphenytoin,
which is sold under the name Cerebyx.
The MRP found that the evidence presented supported the conclusion
that St. Francis and its staff, particularly the pharmacy staff, failed to meet
2 Defendants alleged that the case study, while attached to the MRP’s written opinion and seeming to be exactly descriptive of Nolan’s case, never mentions him by name. This was not an issue until the case was later appealed to this court after rendition of the reconsideration of the summary judgment at issue in this appeal. 3 the applicable standard of care as charged in the complaint and that the
conduct complained of was a factor in the resulting damages. Specifically,
the MRP stated that the pharmacy staff of St. Francis failed particularly in
the preparation of the dose and delivery of the Cerebyx, which was
“inappropriate and incorrect, leading to the Dilantin toxicity and level
increases[.]” Based on this finding, Plaintiffs filed a timely suit against all
Defendants on February 22, 2022, and alleged all of their actions fell below
the standard of care.
Dr. De Soler answered and denied all allegations, except he admitted
that the MRP’s findings as to St. Francis were as recited above. He also
alleged that the findings as to him were not included by counsel and that the
MRP found unanimously that his actions were appropriate and within the
standard of care for a neonatologist. He further alleged that the MRP had
issued a unanimous opinion that the evidence did not support the conclusion
that he had breached any applicable standard of care in Nolan’s treatment.
Nurse practitioners Lirette and Carnes answered together and alleged
that the MRP resulted in a unanimous written opinion in their favor, which
would be presented at trial.
After the answers were filed, Dr. De Soler filed a motion for summary
judgment and sought dismissal of Plaintiffs’ suit because (1) they could not
meet their burden of proof that he had breached any applicable standard of
care, (2) this medical malpractice claim involved issues outside the realm of
a layperson’s understanding and (3) Plaintiffs did not have a medical expert
who could testify that his conduct had breached an applicable standard of
care. On this basis, he sought dismissal of the suit against him.
4 Nurse practitioners Carnes and Lirette collectively filed a motion for
summary judgment on the same basis, i.e., that Plaintiffs lacked an expert
witness to contradict the findings of the MRP that they had not breached the
appropriate standard of care; and, thus, the case against them should be
dismissed.
A hearing on the motions for summary judgment was held on July 28,
2023, and the matter was taken under advisement.
On August 1, 2023, the trial court found that summary judgment
should be granted and issued reasons, stating that Plaintiffs are required to
provide expert witness testimony on the matters at issue and none was
presented. On September 11, 2023, the trial court granted both motions for
summary judgment and dismissed all of Plaintiffs’ claims against
Defendants.
On September 20, 2023, Plaintiffs filed a motion for reconsideration
of the trial court’s granting of Defendants’ motions for summary judgment,
which was granted, effectively allowing Plaintiffs a new trial on those
motions.
Some procedural confusion ensued when Plaintiffs filed a notice for a
devolutive appeal, which the trial court granted. The record was filed with
this court but was dismissed as being prematurely before our court since the
reconsideration of the motions for summary judgment was still outstanding.
On March 11, 2025, the trial court held a hearing to reconsider the
granting of the previous motions for summary judgment. Also at issue was
whether Plaintiffs were required to produce expert testimony to provide
proof of the necessary standard of care, or whether this was a case in which
5 a lay person could infer without it that the medical personnel had committed
malpractice.
On May 6, 2025, a judgment was entered denying Plaintiffs’ motion
for reconsideration and affirming the judgment on the motions for summary
judgment previously entered into the record. Reasons for judgment issued
indicated the trial court found expert testimony was required in this case and
that no such expert had been identified. Plaintiffs appeal the granting of the
motions for summary judgment and the dismissal of their suit against
DISCUSSION
Plaintiffs argue the trial court erred in finding that Defendants were
entitled to summary judgment because it found that they had failed to
produce an expert witness to support their claims in the medical malpractice
case. They contend that expert testimony is not always necessary in order
for a plaintiff to meet his burden of proof in establishing a medical
malpractice claim. Further, they assert that there are instances in which the
medical and factual issues are such that a lay jury can perceive negligence in
the charged physician’s conduct as well as any expert, or in which the
physician testifies as to the standard of care and there is objective evidence
which demonstrates a breach thereof.
Plaintiffs also argue that Defendants’ conduct in this matter was not
complex or complicated but, instead, involved medical and factual issues
that a lay jury could perceive as negligence just as readily as an expert.
They claim that their charges against Defendants are simply that they failed
to monitor the levels of Dilantin administered to Nolan, and that if they had
6 properly done so, he would not now suffer with permanent developmental
delays and related damages.
Defendants argue that summary judgment is appropriate because after
an opportunity for adequate discovery, summary judgment shall be granted
if the motion, memorandum and supporting documents show that there is no
genuine issue as to material fact and that mover is entitled to judgment as a
matter of law. They contend that a claimant in the medical malpractice
action has the burden of proving the degree of knowledge or skill possessed
or ordinarily exercised by physicians, that the defendant either lacked this
degree of knowledge or skill or failed to use reasonable care and diligence
along with his best judgment in application of the skill, and that as a
proximate result of his lack of knowledge or skill or the failure to exercise it,
the plaintiff suffered injuries that otherwise would not have been incurred.
They assert that because Plaintiffs failed to meet their burden of proof,
summary judgment is appropriate in this case.
A summary judgment is reviewed on appeal de novo, with the
appellate court using the same criteria that govern the trial court’s
determination of whether summary judgment is appropriate, i.e., whether
there is any genuine issue of material fact and whether the movant is entitled
to judgment as a matter of law. Samaha v. Rau, 07-1726 (La. 2/26/08),
977 So. 2d 880; Logan v. Richland Par. Hosp., 56,127 (La. App. 2 Cir.
4/9/25), 408 So. 3d 1208, reh’g denied (5/15/25), writ denied, 25-00760 (La.
10/1/25), 417 So. 3d 570. A motion for summary judgment shall be granted
if the motion, memorandum and supporting documents show that there is no
genuine issue as to a material fact and that the mover is entitled to judgment
7 as a matter of law. La. C.C.P. art. 966(A)(3); Staten v. Glenwood Reg’l
Med. Ctr., 53,220 (La. App. 2 Cir. 1/29/20), 290 So. 3d 280, writ denied,
20-00591 (La. 9/23/20), 301 So. 3d 1184. The burden of proof on a
summary judgment motion remains with the mover. La. C.C.P.
art. 966(D)(1). However, if the moving party will not bear the burden of
proof on the issue at trial and points out that there is an absence of factual
support for one or more elements essential to the adverse party’s claim,
action, or defense, then the nonmoving party must produce factual support
sufficient to establish that he will be able to satisfy his evidentiary burden of
proof at trial. Id.; Staten, supra. If the opponent of the motion fails to do so,
there is no genuine issue of material fact and summary judgment should be
granted. Staten, supra.
In a medical malpractice action, the plaintiff has the burden of
proving: (1) the applicable standard of care, (2) that the standard of care was
breached and (3) that as a proximate result of the breach, the plaintiff
sustained injuries that would not otherwise have been incurred. La.
R.S. 9:2794(A); Staten, supra. Expert testimony is generally required to
establish the applicable standard of care and whether that standard was
breached, except where the negligence is so obvious that a lay person can
infer negligence without the guidance of expert testimony. Samaha v. Rau,
supra; Staten, supra. The requirement of producing expert medical
testimony is especially apt when the defendants have filed summary
judgment motions and supported such motions with expert opinion evidence
that their treatment met the applicable standard of care. Staten, supra.
8 In Samaha, supra, the Louisiana Supreme Court observed that “by
law, the report of the expert opinion reached by the medical review panel is
admissible as evidence in any action subsequently brought by the claimant in
a court of law” and that “[t]his undoubtedly includes a summary judgment
proceeding in a medical malpractice lawsuit.” It is well settled that a
defendant-health care provider can use the medical review panel’s favorable
opinion to support a summary judgment motion. Staten, supra.
The only documents that may be filed or referenced in support of or in
opposition to the motion are pleadings, memoranda, affidavits, depositions,
answers to interrogatories, certified medical records, certified copies of
public documents or public records, certified copies of insurance policies,
authentic acts, private acts duly acknowledged, promissory notes and
assignments thereof, written stipulations and admissions. La. C.C.P.
art. 966(A)(4).
Plaintiffs failed to obtain any expert witness to support their
contention that Defendants breached the applicable standard of care and that
the breach caused the damages alleged. This is a very complicated medical
malpractice case and does not present facts from which a layperson could
infer negligence without the guidance of an expert in the field of
neonatology. Plaintiffs have failed to meet their burden of proof to show
that genuine issues of material fact remain; and, therefore, summary
judgment is appropriate. For these reasons, this assignment of error is
without merit.
CONCLUSION
For the foregoing reasons, we affirm the granting of the motions for
summary judgment in favor of Defendants Marc De Soler, M.D., Amanda 9 Carnes, NNP, and Kathleen Lirette, NNP. Costs of the appeal are assessed
to Plaintiffs Christopher Spires and Laura Lively.
AFFIRMED.